skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the Ci PA Initiative

Authors:
 [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [2];  [3];  [4];  [4];  [4];  [5];  [1]
  1. Division of Applied Regulatory ScienceOffice of Clinical PharmacologyOffice of Translational SciencesCenter for Drug Evaluation and ResearchU.S. Food and Drug Administration Silver Spring Maryland USA
  2. Department of Computer ScienceHealthcare InformaticsUniversity of Oxford Oxford UK
  3. Centre for Mathematical Medicine &, BiologySchool of Mathematical SciencesUniversity of Nottingham Nottingham UK
  4. Charles River Laboratories Wilmington Massachusetts USA
  5. CytoBioscienceNew OrleansLouisianaUSA
Publication Date:
Sponsoring Org.:
USDOE
OSTI Identifier:
1493112
Alternate Identifier(s):
OSTI ID: 1511073
Resource Type:
Published Article
Journal Name:
Clinical Pharmacology and Therapeutics
Additional Journal Information:
[Journal Name: Clinical Pharmacology and Therapeutics Journal Volume: 105 Journal Issue: 2]; Journal ID: ISSN 0009-9236
Publisher:
Wiley Blackwell (John Wiley & Sons)
Country of Publication:
United States
Language:
English

Citation Formats

Li, Zhihua, Ridder, Bradley J., Han, Xiaomei, Wu, Wendy W., Sheng, Jiansong, Tran, Phu N., Wu, Min, Randolph, Aaron, Johnstone, Ross H., Mirams, Gary R., Kuryshev, Yuri, Kramer, James, Wu, Caiyun, Crumb, Jr., William J., and Strauss, David G. Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the Ci PA Initiative. United States: N. p., 2018. Web. doi:10.1002/cpt.1184.
Li, Zhihua, Ridder, Bradley J., Han, Xiaomei, Wu, Wendy W., Sheng, Jiansong, Tran, Phu N., Wu, Min, Randolph, Aaron, Johnstone, Ross H., Mirams, Gary R., Kuryshev, Yuri, Kramer, James, Wu, Caiyun, Crumb, Jr., William J., & Strauss, David G. Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the Ci PA Initiative. United States. doi:10.1002/cpt.1184.
Li, Zhihua, Ridder, Bradley J., Han, Xiaomei, Wu, Wendy W., Sheng, Jiansong, Tran, Phu N., Wu, Min, Randolph, Aaron, Johnstone, Ross H., Mirams, Gary R., Kuryshev, Yuri, Kramer, James, Wu, Caiyun, Crumb, Jr., William J., and Strauss, David G. Mon . "Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the Ci PA Initiative". United States. doi:10.1002/cpt.1184.
@article{osti_1493112,
title = {Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the Ci PA Initiative},
author = {Li, Zhihua and Ridder, Bradley J. and Han, Xiaomei and Wu, Wendy W. and Sheng, Jiansong and Tran, Phu N. and Wu, Min and Randolph, Aaron and Johnstone, Ross H. and Mirams, Gary R. and Kuryshev, Yuri and Kramer, James and Wu, Caiyun and Crumb, Jr., William J. and Strauss, David G.},
abstractNote = {},
doi = {10.1002/cpt.1184},
journal = {Clinical Pharmacology and Therapeutics},
number = [2],
volume = [105],
place = {United States},
year = {2018},
month = {8}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record
DOI: 10.1002/cpt.1184

Citation Metrics:
Cited by: 12 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel
journal, September 2016

  • Crumb, William J.; Vicente, Jose; Johannesen, Lars
  • Journal of Pharmacological and Toxicological Methods, Vol. 81
  • DOI: 10.1016/j.vascn.2016.03.009

Convergence of models of human ventricular myocyte electrophysiology after global optimization to recapitulate clinical long QT phenotypes
journal, November 2016

  • Mann, Stefan A.; Imtiaz, Mohammad; Winbo, Annika
  • Journal of Molecular and Cellular Cardiology, Vol. 100
  • DOI: 10.1016/j.yjmcc.2016.09.011

Screening system for drug-induced arrhythmogenic risk combining a patch clamp and heart simulator
journal, May 2015

  • Okada, Jun-ichi; Yoshinaga, Takashi; Kurokawa, Junko
  • Science Advances, Vol. 1, Issue 4
  • DOI: 10.1126/sciadv.1400142

Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures
journal, January 2010


Mechanistic Model-Informed Proarrhythmic Risk Assessment of Drugs: Review of the “CiPA” Initiative and Design of a Prospective Clinical Validation Study
journal, November 2017

  • Vicente, Jose; Zusterzeel, Robbert; Johannesen, Lars
  • Clinical Pharmacology & Therapeutics, Vol. 103, Issue 1
  • DOI: 10.1002/cpt.896

When and How Can Endpoints Be Changed after Initiation of a Randomized Clinical Trial
journal, April 2007


MICE Models: Superior to the HERG Model in Predicting Torsade de Pointes
journal, July 2013

  • Kramer, James; Obejero-Paz, Carlos A.; Myatt, Glenn
  • Scientific Reports, Vol. 3, Issue 1
  • DOI: 10.1038/srep02100

Role of concentration-dependent plasma protein binding in disopyramide disposition
journal, February 1979

  • Meffin, Peter J.; Robert, Edward W.; Winkle, Roger A.
  • Journal of Pharmacokinetics and Biopharmaceutics, Vol. 7, Issue 1
  • DOI: 10.1007/BF01059439

Optimization of an In silico Cardiac Cell Model for Proarrhythmia Risk Assessment
journal, August 2017


Simulation of multiple ion channel block provides improved early prediction of compounds’ clinical torsadogenic risk
journal, February 2011

  • Mirams, Gary R.; Cui, Yi; Sher, Anna
  • Cardiovascular Research, Vol. 91, Issue 1
  • DOI: 10.1093/cvr/cvr044

Validation of Biomarker-Based Risk Prediction Models
journal, October 2008


Cellular basis of drug-induced torsades de pointes
journal, August 2008


QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone: RISPERIDONE METABOLISM AND QT INTERVAL
journal, December 2011

  • Suzuki, Yutaro; Fukui, Naoki; Watanabe, Junzo
  • Human Psychopharmacology: Clinical and Experimental, Vol. 27, Issue 1
  • DOI: 10.1002/hup.1258

Domperidone and Ventricular Arrhythmia or Sudden Cardiac Death: A Population-Based Case-Control Study in the Netherlands
journal, January 2010


Improving the In Silico Assessment of Proarrhythmia Risk by Combining hERG (Human Ether-à-go-go-Related Gene) Channel–Drug Binding Kinetics and Multichannel Pharmacology
journal, February 2017

  • Li, Zhihua; Dutta, Sara; Sheng, Jiansong
  • Circulation: Arrhythmia and Electrophysiology, Vol. 10, Issue 2
  • DOI: 10.1161/CIRCEP.116.004628

Early afterdepolarisation tendency as a simulated pro-arrhythmic risk indicator
journal, January 2017

  • McMillan, Beth; Gavaghan, David J.; Mirams, Gary R.
  • Toxicology Research, Vol. 6, Issue 6
  • DOI: 10.1039/C7TX00141J

Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37°C: Cisapride versus dofetilide
journal, March 2010

  • Milnes, James T.; Witchel, Harry J.; Leaney, Joanne L.
  • Journal of Pharmacological and Toxicological Methods, Vol. 61, Issue 2
  • DOI: 10.1016/j.vascn.2010.02.007

Simulation of the Undiseased Human Cardiac Ventricular Action Potential: Model Formulation and Experimental Validation
journal, May 2011


β-Blockers Protect Against Dispersion of Repolarization During Exercise in Congenital Long-QT Syndrome Type 1
journal, June 2011


Human In Silico Drug Trials Demonstrate Higher Accuracy than Animal Models in Predicting Clinical Pro-Arrhythmic Cardiotoxicity
journal, September 2017


Complex versus simple models: ion-channel cardiac toxicity prediction
journal, January 2018


The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative — Update on progress
journal, September 2016

  • Colatsky, Thomas; Fermini, Bernard; Gintant, Gary
  • Journal of Pharmacological and Toxicological Methods, Vol. 81
  • DOI: 10.1016/j.vascn.2016.06.002

RSD1235 blocks late INa and suppresses early afterdepolarizations and torsades de pointes induced by class III agents
journal, June 2006


Early assessment of proarrhythmic risk of drugs using the in vitro data and single-cell-based in silico models: proof of concept
journal, November 2016


Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium
journal, March 2014


Global Optimization of Ventricular Myocyte Model to Multi-Variable Objective Improves Predictions of Drug-Induced Torsades de Pointes
journal, December 2017

  • Krogh-Madsen, Trine; Jacobson, Anna F.; Ortega, Francis A.
  • Frontiers in Physiology, Vol. 8
  • DOI: 10.3389/fphys.2017.01059

Pharmacokinetic Factors in the Adverse Cardiovascular Effects of Antipsychotic Drugs
journal, January 2004


Improved Prediction of Drug-Induced Torsades de Pointes Through Simulations of Dynamics and Machine Learning Algorithms
journal, May 2016

  • Lancaster, M. Cummins; Sobie, Ea
  • Clinical Pharmacology & Therapeutics, Vol. 100, Issue 4
  • DOI: 10.1002/cpt.367

Torsades de Pointes Ventricular Tachycardia Induced by Clarithromycin and Disopyramide in the Presence of Hypokalemia
journal, April 1999